Sharanya received her PhD from the University of Houston, where she focused on developing zebrafish-based screening models for evaluating chemical toxicity, and mechanisms of toxicant-induced endocrine disruption and metabolic disease. She then pursued a postdoctoral position at Arizona State University, where she trained in CRISPR and stem cell technologies. In our lab, Sharanya explores potential therapies for our zebrafish models of HCC. When not in the lab, Sharanya enjoys hiking, a good book/movie, or exploring local culture.